CLRB To Report WM Trial Data In 2H, DICE On Watch, URGN Sees 46%-67% Revenue Growth In 2022
The following are some of the companies that reported fourth-quarter results and provided corporate updates on Monday. 1. Caribou Biosciences Inc. (CRBU), which successfully completed its IPO last year, is … Read More
